CN104745536B - A kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 and monoclonal antibody - Google Patents
A kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 and monoclonal antibody Download PDFInfo
- Publication number
- CN104745536B CN104745536B CN201510093458.0A CN201510093458A CN104745536B CN 104745536 B CN104745536 B CN 104745536B CN 201510093458 A CN201510093458 A CN 201510093458A CN 104745536 B CN104745536 B CN 104745536B
- Authority
- CN
- China
- Prior art keywords
- tgvp1
- monoclonal antibody
- protein
- albumen
- toxoplasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 and monoclonal antibody.Toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 of the present invention is preserved in China typical culture collection center on December 16th, 2014, and preserving number is CCTCC NO:C2014231.Mouse is immunized with toxoplasma protein TgVP1 synthetic peptides in the present invention, resisting toxoplasmosis albumen TgVP1 hybridoma cell strain 3A6 is obtained by hybridoma technology, the monoclonal antibody secreted by it can be with specific recognition TgVP1 albumen, available for the identification of TgVP1 albumen in experiment, there is application value.
Description
Technical field
The present invention relates to cell engineering field, and in particular to toxoplasma protein TgVP1 monoclonal antibody hybridoma cell strains
3A6 and monoclonal antibody.
Background technology
V-H+-PPase is a kind of unique proton pump, is all existed in a variety of animals and plants.It can hydrolyze inorganic burnt phosphorus
The phosphoric anhydride bonds of hydrochlorate, and utilize discharged energy to transport proton, produce the electrochemical gradient of cross-film, performance and proton pump
The similar effect of ATP enzyme.V-H+-Ppase can make the energy efficient of storage be converted into H+ and/or electric transferring film gradient, for a variety of
Different intracellular transport processes.V-PPases is found to be present in plant and photosynthetic bacteria earliest, recent studies suggest that cone
There is also this enzyme for worm, Leishmania, Infection of Toxoplasma Gondii, plasmodium falciparum.It is worth noting that in the animal place of these parasites
This enzyme is not present in master, therefore V-PPases has important research valency as the potential drug target of parasitic disease
Value.The V-PPases of Infection of Toxoplasma Gondii is distributed mainly on acid calcium body and plasma membrane, can be divided into two species according to the difference of 26S Proteasome Structure and Function
Type, VP1 and VP2.TgVP1 needs K+ to activate its biological activity.When Infection of Toxoplasma Gondii invades cell, TgVP1 composition cyclic structures
Infection of Toxoplasma Gondii outer rim is distributed in, and as the intrusion of Infection of Toxoplasma Gondii is in worm vivo migration.When Infection of Toxoplasma Gondii completes invasive procedure, TgVP1
Come back to the top of Infection of Toxoplasma Gondii.TgVP1 contains 17 membrane-spanning domains, and N-terminal has signal peptide sequence, TgVP1 can be instructed to enter
The secretory pathway of Infection of Toxoplasma Gondii, but specific mechanism of action is still not clear.There are some researches show Infection of Toxoplasma Gondii PPase Activity can suppress to bend
The duplication of shape worm in the cell.Therefore, TgVP1 has the possibility as potential toxoplasmosis clinical diagnosis and therapeutic targets, system
Standby TgVP1 antibody tool is of great significance, and can be that the research of the protein function lay the foundation, while is it as disease
The feasibility of sick mark provides experimental data and supported.
The content of the invention
The purpose of the present invention is overcome the deficiencies in the prior art, there is provided one kind can be used for ELISA, western-blot and exempt from
The resisting toxoplasmosis albumen TgVP1 of epidemic disease fluoroscopic examination monoclonal antibody.
To achieve these goals, the present invention adopts the following technical scheme that:
Detection toxoplasma protein TgVP1 of the present invention antibody is to be exempted from by the use of synthesis TgVP1 antigen polypeptides as antigen
Epidemic disease BALB/c mouse is obtained, and the hybridoma cell strain 3A6 for producing this antibody, hybridoma are obtained with cell-fusion techniques
The antibody of secretion is IgG1 positive, and light chain is κ types.The resisting toxoplasmosis albumen TgVP1 monoclonal antibody hybridoma 3A6, in
It is preserved in China typical culture collection center on December 16th, 2014, preserving number is CCTCC NO:C2014231.
Toxoplasma protein TgVP1 amino acid sequence is EPT25031.1 in the present invention, such as SEQ ID NO:Shown in 1.
Toxoplasma protein TgVP1 antigen polypeptide sequence such as SEQ ID NO in the present invention:Shown in 2.
Described preserving number is CCTCC NO:C2014231 hybridoma cell strain 3A6 preparation method is:TgVP1 resists
Former polypeptide and the keyhole blood indigo plant carrier protein KLH of maleic amide activation, are mixed after desalting and purifying as immunogene with adjuvant
Immune BALB/c mouse is closed, is during which immunized more than twice, takes serum titer to be more than 1:105BALB/c mouse splenocyte with
SP2/0 myeloma cell is merged with 50%PEG-4000 according to a conventional method;With the HAT RPMI- containing 20% calf serum
1640 Screening of Media fused cells, elisa plate is coated with TgVP1 antigen polypeptides, carries out ELISA screenings;By repeatedly limited
Dilution, the hybridoma cell strain of the anti-TgVP1 monoclonal antibodies of stably excreting is finally obtained, labeled as 3A6.Using this plant of hybridoma
Cell is with 1 × 106/ only amount injection paraffin pretreatment 8-10 week old BALB/c female mices abdominal cavity, breeding observing 10-14
Ascites is extracted when mouse web portion expands after it.Purified using affinity chromatography Protein G Sepharose Fast Flow single
Clonal antibody, the purity of monoclonal antibody is identified with SDS-PAGE, and purity reaches more than 90%.
Compared with prior art, the present invention has the advantages that:
The present invention is coated with elisa plate with the TgVP1 antigen polypeptides that synthesize, by the activity of ELISA method detection antibody purification,
And Western-blot is carried out to the toxoplasma protein of purifying with this antibody purification prove that the antibody can identify TgVP1 albumen.
The immunofluorescence dyeing that this antibody purification is used to carry out Infection of Toxoplasma Gondii by the present invention proves that it can identify natural TgVP1
Albumen.The monoclonal antibody of this strain of hybridoma secretion lays the foundation for further research TgVP1 functions, while is its conduct
The feasibility of disease marker provides experimental data and supported.
Its immunogene of the monoclonal antibody of the present invention is to be coupled KLH synthesis TgVP1 antigen polypeptides, 29 amino of total length
Acid.The monoclonal antibody of the present invention can also answer in addition to it can apply to ELISA and Western detection denaturation TgVP1 albumen
For the unmodified natural TgVP1 albumen of cellular immunofluorescence detection.It there is no pin Infection of Toxoplasma Gondii TgVP1 specificity anti-both at home and abroad at present
Body, and the antibody of the present invention can not only be combined with albuminate, moreover it is possible to combined with the native protein with higher structure, so as to
Tested applied to immunofluorescence etc..The monoclonal antibody of the invention prepared for TgVP1 synthesis small peptides is to detecting TgVP1 albumen
With higher specificity and sensitivity, the application of the antibody using for TgVP1 functional study and its as disease marker
Feasibility provides experimental data and supported.
Brief description of the drawings
Fig. 1 is results of the monoclonal antibody 3A6 of the present invention to Toxoplasma immune trace, and it is about 85kDa that it, which combines the molecular weight of band,.
Swimming lane 1:Loading is toxoplasma tachyzoite crack protein;Swimming lane 2:Loading is OFTu cytolytic proteins;Swimming lane M:Albumen
Marker。
Embodiment
The following example is intended to illustrate rather than limit the present invention.
The preparation and identification of 1 monoclonal antibody of the present invention of embodiment
1st, monoclonal antibody 3A6 preparation
1) design, preparation and the carrier conjugation of Infection of Toxoplasma Gondii TgVP1 antigen polypeptides
According to the Infection of Toxoplasma Gondii TgVP1 sequence (accession number on GenBank:EPT25031.1 Infection of Toxoplasma Gondii TgVP1 albumen) is obtained
Sequence, contain 816 amino acid.With the membrane-spanning domain of TMHMM software analysis TgVP1 albumen, IEDB software analysis TgVP1 albumen is exempted from
Epidemic focus, hydrophilic and hydrophobic and surface accessibility, the results showed that Infection of Toxoplasma Gondii TgVP1 protein 29s 2-320aa has 29 amino acid antigens
Property, hydrophily and surface accessibility are stronger.By above-mentioned analysis, the final peptide sequence that screens is:292aa-320aa, SEQ ID
NO:2.The small peptide (TgVP1-P1) and C-terminal coupling keyhole blood indigo plant carrier protein KLH small peptide (TgVP1-P1-KLH) are by Shang Haiji
Your biochemical corp synthesizes.
2) mouse is immunized
6-8 week old female BAl BIc/c mouse are immunized with synthetic peptide TgVP1-P1-KLH.
It is immune for the first time:After taking synthetic peptide TgVP1-P1-KLH to be mixed with isometric Bentonite adjuvants, with every 50
μ g/500 μ L amount intraperitoneal injection BALB/c mouse;
Second immune:After 2 weeks, after taking synthetic peptide TgVP1-P1-KLH to be mixed with isometric Bentonite adjuvants,
With every 50 μ g/500 μ L amount intraperitoneal injection BALB/c mouse;
Third time is immune:Again after 2 weeks, synthetic peptide TgVP1-P1-KLH is taken to be mixed with isometric Bentonite adjuvants
Afterwards, BALB/c mouse is injected intraperitoneally with every 50 μ g/500 μ L amount;Mouse tail vein takes blood after third time is immune 10 days, to close
It is coated with into peptide TgVP1-P1, ELISA detection serum titers, takes potency to be more than 1:105Mouse boosting cell enter with myeloma cell
Row fusion;
Bentonite adjuvant commodity in use products.
3) immune serum titration
Immune serum potency is determined using indirect elisa method.50 μ g synthetic peptides TgVP1-P1 are taken to be dissolved in 10ml 0.05M
PH9.6 carbonate buffer solutions, micro- 96 orifice plate of polystyrene is coated with, 100 μ l/ holes, 4 DEG C overnight.(contain 0.05% (V/ using PBS
V) Tween-20) board-washing three times, with the μ l/ holes of 10mM PBS confining liquids containing 1%BSA 100,37 DEG C of closing 2h, (contained using PBS
0.05% (V/V) Tween-20) board-washing three times, mouse tail vein blood sampling in 10 days after third time is immune, mouse immune serum, which is used, contains 1%
BSA 10mM PBS carry out 10-2~10-8Dilute again, add 96 orifice plates, 100 37 DEG C of μ l/ holes 1h, PBS (contain 0.05% (V/V)
Tween-20) board-washing three times after, add 1:10000 times of dilution horseradish peroxidase-labeled goat anti-mouse iggs (Sigma,
INC.), 100 37 DEG C of μ l/ holes 30min, ibid after board-washing, TMB colour developings, 100 μ l/ holes, room temperature lucifuge 10min, 50 μ l/ hole 2M are added
H2SO2Terminating reaction, 450nm absorption values are surveyed, using immune preceding mice serum as negative control, must be compared with measured value and control value
>=2.1 judge the potency of immune serum to be positive.
4) preparation of hybridoma
Serum titer is taken to be more than 1:105Mouse, 3 days before fusion, take synthetic peptide TgVP1-P1 and isometric PBS to mix
Afterwards, booster immunization is carried out with every 50 μ g/500 μ L amount intraperitoneal injection BALB/c mouse to be fused.It is sterile to take mouse spleen, system
The murine myeloma cell strain SP2/0 of splenoblast suspension and exponential phase presses 1:1 ratio mixing, 1000 × g room temperatures from
Heart 5min, abandons supernatant, flicks centrifugation bottom of the tube with finger, makes precipitation loose, and centrifuge tube is placed in 37 DEG C of water-baths, will be in 37 DEG C of water
50% polyethylene glycol (PEG, MW4000, Sigma) of bath insulation is added in centrifuge tube with dropper is one after another drop of, and centrifugation is shaken in drop
Pipe, drip off in 1min, 2min stood after dripping off, every 1 minute culture medium 1ml, 2ml of serum-free 1640 for adding 37 DEG C of preheatings,
3ml, 4ml, 5ml and 10ml terminate the effect of polyethylene glycol, 1000 × g of cell mixture room temperatures centrifugation 5min, abandon supernatant, add
Enter HAT nutrient solutions (hypoxanthine (H), aminopterin-induced syndrome (A) and thymidine (T) (HAT, Sigma)) and cell be gently resuspended,
By cell point into 96 orifice plates, per the μ l of hole 200.After culture three days, cell fusion situation is observed, changes half HAT nutrient solutions, even
The continuous a few days, until there is Clone formation, change within seven days after fusion HT nutrient solutions (hypoxanthine (H) and thymidine (T) (HT,
Sigma)) cultivate.
5) hybridoma of anti-TgVP1 monoclonal antibodies is secreted in screening
Indirect elisa method screens cells and supernatant, selects the higher positive colony hybridoma of potency to carry out sub- gram
Longhua, and with limiting dilution assay continuous cloning 2-3 times, until to 100% cell positive rate, finally obtain stably excreting and resist
TgVP1 cell strain of monoclonal antibody, labeled as 3A6.Positive rate after cloning is frozen up to liquid nitrogen after 100% cell amplification cultivation
Deposit.
6) preparation and purification of ascites
By 3A6 hybridoma cell strains with 1 × 106/ only amount injection atoleine pretreatment 8-10 week old BALB/c
Female mice abdominal cavity, breeding observing extract ascites when mouse web portion expands after 10-14 days.Using affinity chromatography Protein G
Sepharose Fast Flow monoclonal antibody purifications, the purity of monoclonal antibody is determined with SDS-PAGE, and purity reaches 90%
More than.
2nd, the CHARACTERISTICS IDENTIFICATION of monoclonal antibody of the present invention
1) measure of antibody concentration:Through hybridoma CCTCC NO:The purified rear acquisition of ascites prepared by C2014231
TgVP1 monoclonal antibody 3A6, the Smart Spec plus nucleic acid-proteins analyzer produced using BIO-RAD companies are determined, its
Concentration is 1.24mg/ml.
2) antibody subtype is identified:Hybridoma cell strain is identified using the mouse monoclonal antibody hypotype identification kit of Roche companies
Hypotype, the hypotype of 3A6 secretory antibodies is IgG1 types, and light chain is κ chains.
3) the potency identification of antibody purification:50 μ g synthetic peptides TgVP1-P1 are dissolved in 10ml pH9.6 0.05M carbonate bags
By in buffer solution, 96 orifice plates are added, per the μ L of hole 100,4 DEG C overnight.PBS (containing 0.05% (V/V) Tween-20) board-washing three times,
With the μ l/ holes of 10mM PBS confining liquids containing 1%BSA 150,37 DEG C of closing 2h, PBS (containing 0.05% (V/V) Tween-20) is used
Board-washing three times, 100 μ l antibody purifications, 37 DEG C of incubation 1h, PBS (containing 0.05% (V/V) Tween-20) board-washing three is added per hole
Secondary, the sheep anti-mouse igg polyclonal antibody for adding horseradish peroxidase-labeled is secondary antibody, and 37 DEG C are incubated 30min, and PBS (contains
0.05% (V/V) Tween-20) board-washing three times, 100 μ l are added per hole, TMB colour developings, after 37 DEG C are incubated 15min, add 2M
H2SO4Solution terminating reaction, ELIASA detect at absorbance 450nm.
4) the Western blot identifications of antibody:Toxoplasma tachyzoite and OFTu cells are collected respectively, are made after being cracked
Archwise worm crack protein and OFTu crack proteins, loading after being cracked with 2 × SDS lysis buffers, after 10%SDS-PAGE
With Bio-Rad electrotransfers device by protein delivery to pvdf membrane, the closing of 5% skimmed milk power 1h, pH7.4 Tris-HCl are buffered
Liquid (containing 0.1% (V/V) Tween-20) washes film 3 times, each 5min, and 1:1000 add purified hybridoma CCTCC
NO:Anti- TgVP1 monoclonal antibodies 3A6 prepared by C2014231,4 DEG C of overnight incubations, pH7.4 Tris-HCl buffer solutions (contain
0.1% (V/V) Tween-20) film 3 times, each 5min is washed, add 1:The sheep anti-mouse igg polyclonal antibody of 10000 dilutions
(Sigma) it is secondary antibody, is incubated at room temperature 2h, TBST washes film 3 times, unnecessary solution is sucked with filter paper, is laid in clean tin foil
On, add 1.4ml Pierce-Thermo Scientific ECL series Western chemical luminous substrate reaction solutions (A:B=
1:1) film complete wetting, is made in reaction solution, it is rapid to take out, surplus liquid is sucked with filter paper, is laid on another tin foil, is used
Tin foil wraps film, is put into X-ray magazine, develops in dark place.Hybridoma CCTCC NO:It is prepared by C2014231
Anti- TgVP1 monoclonal antibodies 3A6 there is single specific band to Infection of Toxoplasma Gondii crack protein, as a result as shown in Figure 1.
5) identified by immunofluorescence of antibody:Infection of Toxoplasma Gondii smear is prepared, 4% paraformaldehyde fixes 15min, is added dropwise 0.25%
TritonX100,10min is incubated at room temperature, makes cell membrane that there is permeability, so that antibody enters.PBS is washed three times, containing 1%BSA
PBST room temperatures closing 2h.PBS is washed 3 times, then with the monoclonal antibody 3A6 (PBST 1 of the anti-TgVP1 in the present invention:500
Dilution) incubation at room temperature 1.5h.PBS is washed 3 times, the sheep anti-mouse igg (PBST marked with Alexa Fluor 546 (red fluorescence)
1:1000 dilutions) incubation at room temperature 1h.DAPI dyeing (blueness) 10min after PBS washings.After PBS develops a film, seen under fluorescence microscope
Examine.Make negative control with normal mouse serum simultaneously.
As a result:Through hybridoma CCTCC NO in the present invention:Anti- TgVP1 monoclonal antibodies 3A6 prepared by C2014231
Red fluorescence is observed in the Infection of Toxoplasma Gondii cytoplasm of dyeing, it was demonstrated that the anti-TgVP1 antibody in the present invention can recognize that natural
TgVP1 albumen.
Claims (2)
1. a kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6, it is characterised in that be preserved in Chinese Typical Representative culture guarantor
Tibetan center, preservation day are on December 16th, 2014, preserving number CCTCCNO:C2014231.
2. the anti-TgVP1 monoclonal antibodies that toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 described in claim 1 secretes
Application in TgVP1 albumen is identified.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510093458.0A CN104745536B (en) | 2015-03-02 | 2015-03-02 | A kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 and monoclonal antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510093458.0A CN104745536B (en) | 2015-03-02 | 2015-03-02 | A kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 and monoclonal antibody |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104745536A CN104745536A (en) | 2015-07-01 |
CN104745536B true CN104745536B (en) | 2018-03-09 |
Family
ID=53585796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510093458.0A Active CN104745536B (en) | 2015-03-02 | 2015-03-02 | A kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 and monoclonal antibody |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104745536B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105738618B (en) * | 2016-02-02 | 2017-09-29 | 浙江大学 | A kind of Toxophasma gondii detecting kit |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1431513A (en) * | 2003-01-24 | 2003-07-23 | 湖州瑞泽生物技术有限公司 | Immune colloidal gold reagent for detecting IgM antibody of toxoplasma and its preparing method |
CN102288768A (en) * | 2011-09-19 | 2011-12-21 | 厦门市湖里区妇幼保健院 | Toxoplasma gondii IgG (immunoglobulin G) antibody immunoblotting kit and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61196166A (en) * | 1985-02-27 | 1986-08-30 | Eiken Kagaku Kk | Imunological measurement reagent and preparation thereof |
-
2015
- 2015-03-02 CN CN201510093458.0A patent/CN104745536B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1431513A (en) * | 2003-01-24 | 2003-07-23 | 湖州瑞泽生物技术有限公司 | Immune colloidal gold reagent for detecting IgM antibody of toxoplasma and its preparing method |
CN102288768A (en) * | 2011-09-19 | 2011-12-21 | 厦门市湖里区妇幼保健院 | Toxoplasma gondii IgG (immunoglobulin G) antibody immunoblotting kit and preparation method thereof |
Non-Patent Citations (6)
Title |
---|
A Cleavable Propeptide Influences Toxoplasma Infection by Facilitating the Trafficking and Secretion of the TgMIC2–M2AP Invasion Complex;Jill M. Harper等;《Molecular Biology of the Cell》;20061031;第17卷;第4551-4563页 * |
Characterization of a novel organelle in Toxoplasma gondii with similar composition and function to the plant vacuole;Kildare Miranda等;《Molecular Microbiology》;20100505;第76卷(第6期);第1358-1375页,尤其是第1372页左栏第2段 * |
Characterization of the Chloroquine Resistance Transporter Homologue in Toxoplasma gondii;Sally D. Warring等;《Eukaryotic Cell》;20141130;第13卷(第11期);第1360-1370页 * |
TgVTC2 is involved in polyphosphate accumulation in Toxoplasma gondii;Peggy J. Rooneya等;《Molecular & Biochemical Parasitology》;20101230;第176卷(第2期);第121-126页 * |
TSo联合IFN-γ鼻内免疫小鼠诱导的弓形虫IgA抗体特异性免疫应答;殷国荣等;《热带医学杂志》;20041231;第4卷(第6期);第670-673页 * |
国内外10种弓形虫抗体诊断试剂盒的质量比较;辛晓芳等;《中国人兽共患病杂志》;20011231;第17卷(第6期);第117-118页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104745536A (en) | 2015-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112940087B (en) | Common epitope peptide of SARS-CoV and SARS-CoV-2 and its application | |
CN104745534B (en) | A kind of Procalcitonin monoclonal antibody hybridoma 2H4 and monoclonal antibody | |
CN106434568B (en) | Porcine epidemic diarrhea virus resistant S protein hybridoma cell strain and application thereof | |
CN115724958B (en) | Monoclonal antibody of anti-norovirus GII genomic capsid protein VP1 and application thereof | |
CN104862283A (en) | Pair of high-specificity high-affinity monoclonal antibodies capable of binding to human myoglobin and application thereof | |
CN103254312B (en) | Mouse monoclonal antibody and its preparation method and application thereof | |
CN116836270B (en) | Monoclonal antibody of anti-bluetongue virus VP7 protein, preparation method and application | |
CN104745536B (en) | A kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 3A6 and monoclonal antibody | |
CN104745535B (en) | A kind of toxoplasma protein TgVP1 monoclonal antibody hybridomas 1D7 and monoclonal antibody | |
CN101921337B (en) | Antibody against lactate dehydrogenase of plasmodium vivax, related preparation method, hybridoma cell strain and application | |
CN101671655B (en) | Monoclonal antibody hybridoma cell of HIV P24 and application | |
CN103214571B (en) | Murine monoclonal antibody and preparation method and application thereof | |
CN102690788A (en) | Zearalenone anti-idiotypic antibody, preparation method thereof, and application thereof | |
CN104789535B (en) | Anti- methadone metabolin EDDP hybridoma cell strains and its preparation method and application | |
CN105132376B (en) | One can the how individual epitopes of specific recognition HBsAg monoclonal antibody and its application | |
CN108226508A (en) | The monoclonal antibody of anti-human Legumain albumen, hybridoma cell strain and application thereof | |
CN106977605A (en) | Anti- CD19 protein monoclonal antibodies and application thereof | |
CN102818896A (en) | Detection method of nitration modification sites based on specific antibodies and antibody capable of specifically recognizing succinyl-CoA: 3-oxoacid CoA transferase (SCOT) nitration sites | |
CN107043752A (en) | Hybridoma cell strain and the anti-CRH antibody N D19 based on hybridoma cell strain and its application of context of detection | |
CN104046594B (en) | A kind of Orf virus protein ORFV086 monoclonal antibody hybridoma cell strain 2G8D10 and monoclonal antibody thereof | |
CN105319372B (en) | Ractopamine Test paper card and test kit | |
CN110423275A (en) | A kind of G-17 monoclonal antibody and its application | |
CN108642017A (en) | One plant can the anti-conotoxin of stably excreting cell strain of monoclonal antibody and application | |
CN110759988B (en) | Application of porcine NLRP3 truncated fragment as antigen structural protein | |
CN117700560B (en) | Monoclonal antibody against clostridium difficile glutamate dehydrogenase and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |